Selank

Selank is a synthetic heptapeptide derived from the naturally occurring immunomodulatory peptide tuftsin (Thr-Lys-Pro-Arg), with the addition of a Pro-Gly-Pro sequence that enhances its stability and bioavailability. Developed at the Institute of Molecular Genetics of the Russian Academy of Sciences, Selank has been the subject of extensive research into its neurotropic and anxiolytic properties.

Research has demonstrated that Selank modulates several key neurotransmitter systems, including GABAergic, serotonergic, and dopaminergic pathways. Studies indicate that it may influence the balance of inhibitory and excitatory neurotransmission, leading to measurable changes in anxiety-related behaviors in preclinical models without the sedative effects commonly associated with benzodiazepine compounds.

Selank's immunomodulatory properties represent another significant area of investigation. As an analog of tuftsin, it retains and potentially enhances the parent molecule's ability to influence immune cell function. Research has explored its effects on cytokine expression, natural killer cell activity, and overall immune surveillance, suggesting a dual role in both neural and immune regulation.

Preclinical studies have also investigated Selank's effects on brain-derived neurotrophic factor (BDNF) expression and other neurotrophins involved in synaptic plasticity and neuronal health. These findings suggest potential applications in research related to cognitive function, memory consolidation, and neuroprotection under various experimental conditions.